Orchid Pharma Reports Q1 FY27 Unaudited Results

Orchid Pharma Ltd announced its unaudited financial results for the first quarter of FY2026-27 ended June 30, 2026. The company reported a Profit After Tax of ₹1,193.72 lakhs on a standalone basis. The Board of Directors approved these results, along with the auditors' review reports. The filing also detailed the impact of the amalgamation with Dhanuka Laboratories Limited, effective from April 01, 2024, and the completion of acquisitions related to Allecra Therapeutics and Orchid Pharma Europe GmbH. The company continues to monitor developments regarding new labor codes.